Using pulsed radiofrequency and platelet-rich plasma to treat glossopharyngeal neuralgia
Official title: Efficacy and Safety of the Application of Pulsed Radiofrequency, Combined With Platelet Rich Plasma, to the Treatment of Idiopathic Glossopharyngeal Neuralgia (GPN): A Study Protocol for a Multi-Center, Prospective, Open-Label, Propensity Score Match Cohort Study
Run by Beijing Tiantan Hospital · NCT06931457 · Data updated 2026-11-12
This study is testing if combining pulsed radiofrequency treatment with platelet-rich plasma can help adults with glossopharyngeal neuralgia who haven't found relief from medications.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 121 (estimated) |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | May 1, 2025 |
| Main results expected | May 1, 2027 |
| Study ends | June 1, 2027 |
| Registry record updated | July 3, 2025 |
| Trial ID | NCT06931457 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 diagnosed with idiopathic GPN who have not responded to or cannot tolerate conventional medications.
✕Probably not a fit
Patients with bilateral GPN or those with significant medical contraindications such as infections or previous mental illness may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness and safety of combining pulsed radiofrequency (PRF) treatment with platelet-rich plasma (PRP) for patients suffering from idiopathic glossopharyngeal neuralgia (GPN). Participants must be over 18 years old and have previously failed pharmacotherapy or experienced intolerable side effects from medications. The study will monitor patients undergoing PRF treatment for GPN, with follow-up assessments conducted for at least one month to evaluate outcomes. The goal is to determine if this combined approach can provide better relief from symptoms compared to standard treatments.
Why it matters
Potential benefit: If successful, this approach could offer a new, effective treatment option for patients suffering from glossopharyngeal neuralgia.
How similar studies have gone: While the combination of PRF and PRP is a novel approach, similar studies have shown promise in treating other neuralgias, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. age \>18 years; 2. diagnosed with idiopathic GPN according to the third International Classification of Headache Disorders (ICHD) classification; 3. patients who failed pharmacotherapy or intolerable side effects of medication; 4. undergoing PRF for GPN; 5. at least 1 month of follow-up recordings. Exclusion Criteria: 1. Patients with bilateral GPN; 2. Abnormalities in blood measurements, liver and kidney function, blood glucose, coagulation, electrocardiography or chest radiography; 3. Infection at the puncture site; 4. Previous mental illness; 5. Previous history of narcotic drug abuse; 6. Prior anticoagulant or antiplatelet therapy; 7. An implantable pulse generator; 8. Current pregnancy or breast feeding. 9. Patients with incomplete medical records (lack of baseline data or postoperative follow-up data).
Where it's running
-
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Fang Luo, M.D.
- Email: 13611326978@163.com
- Phone: +86 13611326978
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using a patient’s own fat mixed with platelet-rich fibrin to rebuild the breast after conservation surgery
Aiming to see if a patient’s own fat mixed with platelet-rich fibrin can help restore breast shape after breast-conserving cancer surgery.
-
Platelet-Rich Plasma from Two Different Systems in Knee Osteoarthritis
This study compares PRP made by two FDA-approved machines to see if the platelets differ and whether injections help knee symptoms.
-
PRP with fractional CO₂ laser to improve acne scars
This will test whether adding your own platelet-rich plasma (PRP) to fractional CO₂ laser treatment can improve moderate-to-severe acne scars in adults aged 18–40.
-
Pulsed radiofrequency to shoulder nerves versus the brachial plexus for chronic post‑mastectomy shoulder pain
This will test whether pulsed radiofrequency to the brachial plexus or to individual shoulder nerves helps reduce chronic shoulder pain after mastectomy.
-
Combining pulsed radiofrequency and platelet-rich plasma for treating facial pain
This study is testing whether combining a special type of injection with a new pain treatment can help people with stubborn facial pain who haven't found relief from other methods.
-
Combining microfracture surgery with platelet-rich plasma injection for ankle cartilage repair
This study is testing if adding a platelet-rich plasma injection to microfracture surgery can help people with ankle cartilage damage feel better and recover more effectively.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.